Title:
Operation of the control drug release profile by the Liposome constituent in both water and a non-aqueous division
Document Type and Number:
Japanese Patent JP2016518340
Kind Code:
A
Abstract:
本発明は、少なくとも１つのリポソーム、少なくとも１つの多価対イオン供与体又は薬学的に許容されるその塩、少なくとも１つの一価対イオン供与体又は薬学的に許容されるその塩、及び両親媒性治療薬を含む、医薬組成物に関する。本発明は、本明細書に記載の医薬組成物を投与するステップを含む癌細胞増殖を阻害する方法にも関する。【選択図】図１
More Like This:
Inventors:
Kampei
Tseng Yun-ron
Oh Han Chun
Tseng Yun-ron
Oh Han Chun
Application Number:
JP2016503279A
Publication Date:
June 23, 2016
Filing Date:
March 15, 2014
Export Citation:
Assignee:
Taiwan Liposome Company Limited
TLC by Offer Mathewicals, Inc.
TLC by Offer Mathewicals, Inc.
International Classes:
A61K9/127; A61K31/4745; A61K31/727; A61K31/728; A61K31/731; A61K31/737; A61K38/00; A61K45/00; A61K47/24; A61K47/28; A61P35/00
Domestic Patent References:
| JP2012092119A | 2012-05-17 |
Other References:
GEORGE ZHU, ET AL.,: "The effect of vincristine-polyanion complexes in STEALTH liposomes on pharmacokinetics, toxicity and", CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol. Vol.39, Issue1-2, JPN6017042688, 1996, pages 138 - 142, ISSN: 0003677333
Attorney, Agent or Firm:
Kazuko Fujita
Previous Patent: How to produce a cancer constituent
Next Patent: A compound of the probe based active, a constituent, and directions for use
Next Patent: A compound of the probe based active, a constituent, and directions for use